跳至主要内容
临床试验/NCT07562308
NCT07562308尚未招募不适用

Intravenous Dexmedetomidine Vs. Lidocaine for Laryngeal Mask Insertion Conditions In Pediatric Patients Undergoing Elective Surgeries, A Randomized Controlled Trial.

Assiut University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
First-attempt insertion success rate

研究概览

简要总结

Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. LMA may help in reducing postoperative pulmonary complications. IV Dexmedetomidine Improves LMA Insertion Success and Decreases trials number, While IV Lidocaine Decreases Postoperative Cough. This is a randomized interventional trial comparing both drugs. IV DEX will be compared vs IV lidocaine regarding the feasibility of insertion, number of trials, incidence of cough, postoperative pulmonary complications and hemodynamic profile.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Parental/guardian consent.
  • Age 2-12 years
  • ASA physical status I-II.
  • Elective surgery requiring LMA (duration <2 hours).

排除标准

  • Known airway anomalies (e.g., tonsillar hypertrophy, cleft palate).
  • Cardiovascular disease (bradycardia, arrhythmias).
  • Allergy to study drugs.
  • BMI >95th percentile.

研究组 & 干预措施

Group (D) DEX

Active Comparator

Dose: 0.2 mcg/kg IV in 10 mL saline, infused over 10 min pre-induction.

干预措施: Dexamedomedine (Drug)

Group (L) Lidocaine

Active Comparator

Dose: 1.5 mg/kg IV (max 100 mg) in 10 ml saline over 1 min before induction.

干预措施: Lidocaine (drug) (Drug)

结局指标

主要结局

First-attempt insertion success rate

时间窗: After induction of anesthesia

The success of the first trial of classic LMA insertion will be assessed. Binary: yes or no.

次要结局

  • Ease of insertion (4-point scale)(After Induction of anesthesia)
  • Heart rate(Every 15 minutes till recovery)
  • MAP(Every 15 minutes)
  • Recovery Time(After cessation of anesthesia administration)
  • Postoperative Agitation(In PACU)
  • Postoperative Complications(0,1,2,6 hours postoperative.)
  • PONV(24 hours postoperative)
  • Postoperative sore throat (0-3 scale).(24 hours postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdelrahman Hamdy Mohammed

Lecturer of Anesthesia & ICU, Faculty of Medicine, Assiut University

Assiut University

研究点 (1)

Loading locations...

相似试验